An initial positive experience with weight loss may facilitate the implementation of the recommended lifestyle changes [22]
During the experimentation, the following clinical parameters were monitored daily: coat status, kyphosis, reduced mobility, weight loss, and body temperature
Another study has shown that the level of metabolites such as 2-methyl butyl carnitine, N-acetyl putrescine, amino butanal, carnitine, farnesyl diphosphate, shikimate and uridine were significantly higher in the cerebrospinal fluid (CSF) of GBM patients compared to the CSF of controls [190]
The high cost of GLP-1 medication is the biggest impediment, though consumer adoption has also been hindered by the lack of insurance coverage, drug shortages, and the medications physical side effects